Atlas Trials

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris

Clinical trial NCT00750152 · COMPLETED

Trial details

NCT number
NCT00750152
Sponsor
Merz North America, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Tinea CrurisJock Itch
Start date
2008-09-01
Primary completion
2009-08-01
Enrollment
334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.